1. Home
  2. ARWR vs SBCF Comparison

ARWR vs SBCF Comparison

Compare ARWR & SBCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • SBCF
  • Stock Information
  • Founded
  • ARWR 2003
  • SBCF 1926
  • Country
  • ARWR United States
  • SBCF United States
  • Employees
  • ARWR 525
  • SBCF N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • SBCF Major Banks
  • Sector
  • ARWR Health Care
  • SBCF Finance
  • Exchange
  • ARWR Nasdaq
  • SBCF Nasdaq
  • Market Cap
  • ARWR 2.7B
  • SBCF 2.5B
  • IPO Year
  • ARWR 1993
  • SBCF N/A
  • Fundamental
  • Price
  • ARWR $22.04
  • SBCF $28.42
  • Analyst Decision
  • ARWR Buy
  • SBCF Hold
  • Analyst Count
  • ARWR 12
  • SBCF 5
  • Target Price
  • ARWR $42.70
  • SBCF $28.10
  • AVG Volume (30 Days)
  • ARWR 2.0M
  • SBCF 327.9K
  • Earning Date
  • ARWR 02-04-2025
  • SBCF 01-23-2025
  • Dividend Yield
  • ARWR N/A
  • SBCF 2.55%
  • EPS Growth
  • ARWR N/A
  • SBCF 10.93
  • EPS
  • ARWR N/A
  • SBCF 1.36
  • Revenue
  • ARWR $3,551,000.00
  • SBCF $494,135,000.00
  • Revenue This Year
  • ARWR $4,225.26
  • SBCF N/A
  • Revenue Next Year
  • ARWR $59.48
  • SBCF $8.20
  • P/E Ratio
  • ARWR N/A
  • SBCF $20.76
  • Revenue Growth
  • ARWR N/A
  • SBCF N/A
  • 52 Week Low
  • ARWR $17.05
  • SBCF $21.90
  • 52 Week High
  • ARWR $39.83
  • SBCF $31.68
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 50.44
  • SBCF 42.37
  • Support Level
  • ARWR $21.48
  • SBCF $28.19
  • Resistance Level
  • ARWR $22.47
  • SBCF $29.27
  • Average True Range (ATR)
  • ARWR 1.27
  • SBCF 0.68
  • MACD
  • ARWR -0.23
  • SBCF -0.27
  • Stochastic Oscillator
  • ARWR 12.63
  • SBCF 10.57

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About SBCF Seacoast Banking Corporation of Florida

Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The Company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage, and credit facilities.

Share on Social Networks: